[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,063
Citations 0
Viewpoint
May 2016

The US Food and Drug Administration’s Proposed Rule to Increase Regulation of Indoor Tanning Devices

Author Affiliations
  • 1Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick
  • 2Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts
  • 3Division of Preventive and Behavioral Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester
JAMA Dermatol. 2016;152(5):509-510. doi:10.1001/jamadermatol.2016.0504

Tanning bed use, particularly among teen girls and young adult women, has become a modern-day epidemic in the past 20 years. Numerous studies have established the link between indoor tanning use and skin cancer, including melanoma. Reducing the harms of indoor tanning is one of 5 goals outlined in the 2014 US Surgeon General’s “Call to Action to Prevent Skin Cancer.”1 Consistent with the Call to Action, on December 22, 2015, the US Food and Drug Administration (FDA) issued a proposed rule with the following restrictions for sunlamp products (ie, indoor tanning beds and booths): (1) to ban their use among individuals younger than 18 years; (2) to require prospective users to sign a risk acknowledgment certification; and (3) to provide user manuals to customers and tanning facility operators on request.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×